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THE possibility of testing compounds for carcinogenicity by injecting them
subcutaneously into newborn mice has been discussed by Roe, Rowson and
Salaman (1961). Pietra, Spencer and Shubik (1959) recorded the induction of
malignant lymphoma and lung adenomas in Swiss mice by the injection of only
30 ,ug. 9,10-dimethyl-1,2-benzanthracene (DMBA) on the first day of life. Stich
(1960) obtained a similar result using a 60 ,tg. dose of DMBA. Later, Pietra and
his colleagues (Pietra, Rappaport and Shubik, 1961) confirmed their findings with
DMBA and tested four other known carcinogens: 3,4-benzopyrene, 20-methyl-
cholanthrene, 1,2,5,6-dibenzanthracene and urethane. In this paper the induc-
tion of tumours at sites other than the lung and lymphatic system is described.
Comparable results were reported by Roe, Rowson, and Salaman (1961) using
DMBA in CBA and " 101 "-strain mice, by Fiore-Donati et al. (1961) using
urethane and by Kelly and O'Gara (1961) using 20-methylcholanthrene and
1,2,5,6-dibenzanthracene.
According to the Pullmans' theory of the relation between electronic structure
and carcinogenic activity, 1,2-benzanthracene (BA) is a borderline compound.
The appearance of carcinogenic activity in aromatic hydrocarbons is determined
by the existence ofan optimum charge of or electrons at the K region, the 3,4-bond
in BA. Ifhowever, the molecule also contains an L region this should be inactive.
In BA, the fusion of only one lateral ring to anthracene leaves an L region which
is slightly too reactive so, according to the theory, the compound may be expected
to be either inactive or at most very weakly carcinogenic (Pullman and Pullman,
1955). This theoretically borderline position of BA with respect to carcinogenesis
has been borne out in practice (N.B. doubtless some of the earlier experimental
results were used by the Pullmans when they elaborated their theory). Isolated
tumours of mouse epidermis following skin application of BA were noted by
Kennaway (1930), Cook (1933), Barr et al. (1935) and Hill et al. (1951), but Ander-
vont and Shimkin (1940) found neither skin nor lung tumours after administration
by painting, subcutaneous or intravenous injection in A strain mice. Local
sarcomas developed after 22 months in 8 out of 50 C57B1 mice injected sub-
cutaneously with 5 mg. BA in tricaprylin (Steiner and Falk, 1951). A range of
doses was later tested, the lowest being 0 05 mg., and the minimal effective dose
calculated to be between 0-01 mg. and 0 03 mg. BA (Steiner and Edgecomb,
1952). By the alternate application of 0*05 per cent BA and croton oil for one
year Graffi (1953) obtained 18 benign skin tumours in 9 surviving mice. ThisF. J. C. ROE, B. C. V. MITCHLEY AND MARGARET WALTERS
" initiating " action of BA was confirmed by Roe and Salaman (1955): two
applications of 1 per cent BA followed by 20 applications of 0 5 per cent croton
oil yielded 43 benign tumours in 13 out of 18 surviving mice. Some of these
eventually became malignant though this was not recorded in the paper. No
tumours developed after treatment with 1 per cent BA alone.
Connell (1961) reported the induction oflung andkidney tumours in 89 per cent
of 25 CBA mice given three intraperitoneal injections (200 mg./kg. body weight)
of ethyl methane sulphonate (EMS) at 3-weekly intervals, compared with 2 per
cent in the controls. There was a latent period before the development of the
tumours of almost 2 years. The incidence of hepatomas to which CBA mice are
prone was unaffected by the EMS treatment. Subcutaneous injection of EMS
(29 x 5 mg.) yielded no tumours at the injection site in 20 stock mice, 10
of which survived for 12 months and 3 for 18 months or more after the first
injection (Haddow et al., 1962).
Dogs adequately dosed with 2-naphthylamine (NA) by mouth developed
bladder tumours in 2-5 years (Hueper, Wiley and Wolfe, 1938; Bonser, 1943;
Bonser et al., 1956a). Early neoplastic changes in the bladder epithelium of rats
were seen only after 60 weeks and of rabbits after 5 years (Bonser et al., 1952).
Hepatomas occurred in CBA mice (Bonser et al., 1952), also in rats fed NA in a
diet in which protein was replaced by acid casein hydrolysate and 2 per cent
dl-tryptophan (Boyland, Harris and Horning, 1954). Local sarcomas were in-
duced in 63 per cent of mice injected subcutaneously with an oily solution of NA
which had stood for 4 weeks, though the proportion fell to 8 per cent in animals
treated with freshly-prepared solutions (Bonser et al., 1956a). Bladder implanta-
tion of paraffin wax pellets containing NA in the mouse showed the chemical to
have slight carcinogenic activity (Bonser et al., 195Gb) but an attempt to use the
method in rats was unsuccessful because control animals developed proliferative
lesions which made the interpretation impracticable (Bonser et al., 1953).
Abdominal tumours (mostly sarcomas) occurred in rats injected intraperi-
toneally with 2-naphthylhydroxylamine (NHA) (50 mg./kg. in oil) twice weekly
for three months (Boyland, Dukes and Grover, 1961). Thirteen bladder carci-
nomas were found among 62 surviving mice following bladder implantation of
crushed paraffin wax pellets containing 2-naphthylhydroxylamine (Bonser et al.,
1963).
In the experiments to be described below, these four substances, BA, EMS,
NA and NHA, are tested for carcinogenicity by the technique of injection sub-
cutaneously into mice on the first day of life. In addition, in the case of BA, a
comparison is made of the effects of injecting the same amount on the 1st, 2nd,
4th and 8th days of life.
MATERIALS AND METHODS
Mice.-BALB/c (Bittner agent free) mice of a line maintained in the Institute
by brother-sister mating since 1952 were used. The line was originally obtained
from Dr. H. B. Andervont of the National Cancer Institute, National Institute of
Health, United States Public Health Service. During the experiment the mice
were housed in metal cages and fed cubed diet No. 86 (supplied by Messrs. Dixon
of Ware, Herts.) daily, plus bread and marmite once each week, and water ad
libitum.
Chemical agents.-9,10-dimethyl-1,2-benzanthracene (DMBA), 1,2-benzanthra-
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cene (BA) and 2-naphthylamine (NA) were obtained from L. Light and Co.
Ethyl methane sulphonate (EMS) and 2-naphthylhydroxylamine (NHA) were
prepared in the Institute by Mr. J. L. Everett and Mr. P. L. Grover respectively.
Gelatine powder was supplied by Hopkin and Williams and arachis oil by Damoore
Ltd.
Method of administration.-DMBA, BA and NA were administered as suspen-
sions in 1 per cent aqueous gelatine. These suspensions were prepared by adding
an acetone solution of the agents to aqueous gelatine warmed to 560 C., then
driving off the acetone in a stream of nitrogen while the temperature was
maintained at this level. The dose per mouse was 0-02 ml. of the resulting
suspension. 2-naphthylhydroxylamine was given as a solution in 0-02 ml.
arachis oil, and EMS in 0-02 ml. distilled water.
Observation.-All animals were examined thoroughly once each week and
more cursorily on intervening days. Mice with evidence of malignant lymphoma
or other tumours or which were sick were killed and examined carefully post
mortem. The surfaces of the five lobes of the lung were examined for adeno-
matous lesions. Representative adenomas, doubtful lung lesions and all other
apparently neoplastic lesions were taken for histological section.
EXPERIMENTAL
Experiment I
Newly born litters were allotted randomly to four different test groups (Groups
1-4), two solvent control groups (Groups 5 and 6), one positive control group
(Group 7) and one untreated control group (Group 8). This randomization ex-
tended to Groups 9-11 of Experiment II vide infra. Animals of the test, positive
and solvent control groups were injected once subcutaneously in the interscapular
region when less than 24 hours old. Groups 1-4 received 50 #g. BA, 100 /tg.
EMS, 50 fg. NA, and 50 ,tg. NHA, respectively; groups 5 and 6, 0 02 ml. aqueous
TABLE I :-Results of First Experiment.
Number
of
animals
Dose injected
Survivors
(i.e.
animals
killed
between
36th and
43rd weeks)
Survivors
which
had lung
tumours*
1,2-benzanthracene/l% aqueous 50 yg. 60 52 24 (46%)
gelatine
Ethyl methane sulphonate/dis- 100 ug. 48 . 32 . 17 (53%)
tilled water
2-naphthylamine/aqueous gela- 50 pg. 91 71 15 (21-1%)
tine
2-naphthylhydroxylamine/ara
- 50 pg. . 51 37 . 10 (27%)
chis oil
None . . - 70 . 49 . 3 (6-1%)
1% aqueous gelatine 0.02ml. 28 21 2 (9 5%)
Arachis oil 002ml 63 56 3(5.4%)
9,10-dimethyl-1,2-benzanthra- 30 pg. 52 . 20 20 (100%)
cene/1% aqueous gelatine
Average
lung
tumours
per
survivor
0-61 .
Mice with other
tumours including
malignant
lymphoma
1-malignant
lymphoma
1-34 . 0
0-31 . 1 hepatoma
0 49 . 0
. 0-08 .
0 09
. 0-05 .
27
0
0
0
7t
* i.e. pulmonary adenomas or adenocarcinomas visible on surfaces of lobes.
t 2 malignant lymphomas, 1 thymoma-lymphocytic type, 1 subcutaneous sarcoma at injection site, 1 mam-
mary adenocarcinoma, 1 adenocarcinoma of ovary, 1 parotid rhabdomyosarcoma.
Test substance/Solvent
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gelatine and 0O02 ml. arachis oil; and group 7, 30 ,tg. DMBA. Group 8 received
no treatment.
Litters were housed separately until weaning at which time the mice were
numbered on the ears and rehoused in boxes of 4 to 6 according to group and
sex. A record was kept ofmice which failed to survive till weaning though it was
not possible to examine them post mortem because of cannibalism.
It had been planned to sacrifice the animals when they were one year old, but
an intercurrent epizootic necessitated an earlier termination. The results given
in Table I refer to mice which came to post mortem between the 36th and 43rd
weeks of the experiment, but mostly during the 40th week.
Experiment II
A comparison was made between mice injected during the first 24 hours of
life (Group 1), on the 2nd day (Group 9), on the 4th day (Group 10) and on the
8th day (Group 11) with the same single dose of BA, namely 50 ,tg. This
experiment was run in parallel with Experiment I, litters being randomized
between Groups 1-11. The results are presented in Table II.
TABLE IT:-Results of Second Experiment.
Survivors
(i.e.
animals Average
Number killed Survivors lung
50 lig. 1,2-benzanthracene of between which tumours Mice with other
in 1% aqueous gelatine animals 36th and had lung per tumours including
injected on: injected 43rd week) tumours survivor malignant lymphoma
lst day . 60 . 52 . 24 (46%) . 0-61 1-malignant
lymphoma
2nd day . 42 . 39 . 11 (28.2%) 0-38 0
4th day 50 . 33 10 (30%) . 0-48 . 0
8th day . 58 41 10(24 4%) 0.27 . 1-adenocarcinoma
of sub-lingual gland
Controls injected with 1%
aqueous gelatine only
on:
1st day . 28 . 21 2 (95%) 0 09 . 0
DISCUSSION
In the first experiment a group treated with DMBA was included as a control
to ensure that the strain of mice used was capable of giving a positive response in
this type of test. A high yield of tumours was obtained in this group. The
incidence of tumours in groups given no treatment, or treated with 1 per cent
aqueous gelatine only or arachis oil only, was similar and low. Thus, results in
these solvent and untreated control groups made it clear that the background
" spontaneous " incidence of tumours in our subline of the BALB/c strain is
uniformly and acceptably low; it also provided confidence that the general
environment in our animal houses was unlikely to interfere with the results of the
tests. Against the yardsticks of the results in the positive and negative control
groups we would assess the results obtained with the test substances as follows:
1,2-benzanthracene D
Ethyl methane sulphonate Definitely though weakly active.
2-naphthylamine
2-naphthylhydroxylamine Probably active but results require confirmation.
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From the results of the second experiment we concluded that where a fixed
dose of the test substance was giveni (irrespective of body weight) positive results
were most likely to be obtained in animals injected on the first day of life. Kelly
and O'Gara (1961) found both lung tumour incidence aind mean nodule count
distinctly higher in mice injected when newborn (with dibenz(a,h)anthracene and
3-methylcholanthrene) than in those given the same dose at 1, 3 and 6 weeks of
age. The incidence of stem cell lymphomas in mice injected during the neonatal
period with 100 lig., 75 ,ig. or 50 ,ug. of 7,12-dimethylbenz(a)anthracene was
higher than in mice receiving 1000 ,ig. or 100 lig. at 2 or 4 w%Neeks of age, but lung
adenomas occurred as frequently in the mice treated at 2 weeks as in those treated
when newborn (Toth. Rappaport and Shubik. 1962).
SUMMARY
1. Groups of mice of the BALB/c (Bittner agent free) strain were inijected
when newborn with the following test substances: 50 l/g. 1,2-benzanthracene
(BA) and 50 ,ug. 2-naphthylamine (NA) in aqueous gelatine, 100 ,ig. ethyl methane
sulphonate (EMS) in distilled water and 50 ,ug. 2-naphthylhydroxylamine (NHA)
in arachis oil. Solvent controls were injected with 1 per cent aqueous gelatine
alone and arachis oil alone and a positive control group received 30 fig. 9,10-
dimethyl-1,2-benzanthracene (DMBA) in aqueous gelatine. A further control
group received no treatment.
2. Survivors were killed betweeni the 36th and 43rd weeks of the experimenit
and examined post mortem for tumours at all sites.
3. The incidence of lung and other tumours was high in the DMBA treated
group-and low in the untreated and solvent treated control groups. According
to these standards BA and EMS gave weak but definitely positive results and
NA and NHA doubtful but probably positive results.
4. When the same dose of BA (i.e. 50 fug.) was injected into mice of less thani
24 hours, 24-48 hours, 4 days and 8 days of age, the highest yield of tumours
was obtained in the first group.
We are grateful to Miss Maralis Carter and Miss Bernardette Keogh for their
skilled technical assistance.
This investigation was supported by grants to the Chester B3eatty Research
Institute (Institute of Cancer Research: Royal Cancer Hospital), from the
Medical Research Council (Tobacco Manufacturers' Benefaction), the British
Empire Cancer Campaign, the Aiina Fuller Fund, and the National CancerInstitute
of the National Institutes of Health. U.S. Public Health Service.
REFERENCES
ANDERVONT. H. B. AND SHIMKIN. M. B.-(1940) J. nat. Cancer Inst., 1, 225.
BARRY, G., COOK, J. W., HASLEWOOD, G. A. D., HEWETT, C. L., HIEGER, I. AND KENNA-
WAY, E. I,.-(1935) Proc. Roy. Soc.? B, 117. 318.
BONSER, G. M.-(1943) J. Path. Bact.. 55. 1.
Idem, BOYLAND, E., BUSBY, E. R., CLAYSON. D. B., GROVER, P. L. AND JULL, J. W.-
(1963) Brit. J. Cancer, 17, 127.
Idemn, BRADSHAW, L., CLAYSON, D. B. AND JULL, J. W.-(1956b) Ibid., 10, 539.
Idem, CLAYSON, D. B.. JULL, J. W. AND PYRAH, L. N.-(1952) Ibid., 6, 412. (1953)
Ibid.. 7, 456.-(1956a) Ibid., 10. 533.260 F. J. C. ROE, B. C. V. MITCHLEY AND MARGARET WALTERS
BOYLAND, E., DUKES, C. E. AND GROVER, P. L.-(1961) Rep. Brit. Emp. Cancer Campgn,
39, 81.
BOYLAND, E., HARRIS, J. AND HORNING, E. S.-(1954) Brit. J. Cancer, 8, 647.
CONNELL, D. I.-(1961) Rep. Brit. Emp. Cancer Campgn, 39, 77.
COOK, J. W.-(1933) Congr. int. Cancer, 2, 373.
FIORE-DONATI, L., CHIECO-BIANCHI, L., DE BENEDICTIS, G. AND MAIORANO, G.-(1961)
Nature, Lond., 190, 278.
GRAFFI, A.-(1933) Schweiz. med. Wschr., 83, 865.
HADDOW, A., DUKES, C. E., ROE, F. J. C., MITCHLEY, B. C. V. AND EVERETT, J. L.-
(1962) Rep. Brit. Emp. Cancer Campgn, 40, 30.
HILL, W. T., STANGER, D. W., PIzzo, A., RIEGEL, B., SHUBIK, P. AND WARTMAN,
W. B.-(1951) Cancer Res., 11, 892.
HUEPER, W. C., WILEY, F. H. AND WOLFE, H. D.-(1938) J. industr. Hyg., 20, 46.
KELLY, M. G. AND O'GARA, R. W.-(1961) J. nat. Cancer Inst., 26, 651.
KENNAWAY, E. L.-(1930) Biochem. J., 24, 497.
PIETRA, G., RAPPAPORT, H. AND SHUBIK, P.-(1961) Cancer, 14, 308.
Idem, SPENCER, K. AND SHUBIK, P.-(1959) Nature, Lond., 183, 1689.
PULLMAN, A. AND PULLMAN, B.-(1955) Advanc. Cancer Res., 3, 117.
ROE, F. J. C., ROWSON, K. E. K. AND SALAMAN, M. H.-(1961) Brit. J. Cancer, 15, 515.
IdeM AND SALAMAN, M. H.-(1955) Ibid., 9, 177.
STEINER, P. E. AND EDGECOMB, J. H.-(1952) Cancer Res., 12, 657.
Idem AND FALK, H. L.-(1951) Ibid, 11, 56.
STICH, H. F.-(1960) J. nat. Cancer Inst., 25, 649.
TOTH, B., RAPPAPORT, H. AND SHIUBIK, P.-(1963) J. nat. Cancer Inst., 30, 723.